← Eichor
Condition: System Sclerosis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: System Sclerosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Non-invasive Brain Stimulation and Exercise Intervention for Patients With Motor Neuron Disease
NA · 1 location(s) · Chulalongkorn University · NCT07067229Clinical Research in ALS Study
Phase N/A · 1 location(s) · University of Miami · NCT00136500Foot Muscles Training in Sclerosis
NA · 1 location(s) · Inés Llamas-Ramos · NCT06665607Comparison of Diagnostic Performances of 3D FLAIR, DIR and PSIR Sequences in Optic Neuritis
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT06494228Periodontal Microbiota in Systemic Sclerosis
NA · 1 location(s) · University Hospital, Strasbourg, France · NCT06182293Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammato
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06599411Bringing the Outdoors In: Virtual Nature Walks for Depression in Multiple Sclerosis (MS) Patients
NA · 1 location(s) · University of Michigan · NCT07392879Skeletal Muscle Aging and Responsiveness in Aged People With MS
NA · 1 location(s) · Oklahoma Medical Research Foundation · NCT07500727US Zamto-cel Autoimmune Diseases
Phase 1 · 1 location(s) · Miltenyi Biomedicine GmbH · NCT06708845Study of Diosmin for the Treatment of Digital Ulcers in Systemic Sclerosis
NA · 5 location(s) · Primus Pharmaceuticals · NCT06256575Lorraine Registry of Multiple Sclerosis
Phase N/A · 1 location(s) · Central Hospital, Nancy, France · NCT02883335Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
NA · 1 location(s) · Cionic, Inc. · NCT05964829A Study to Evaluate Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Ublituximab Administered at Various Injection
Phase 2 · 39 location(s) · TG Therapeutics, Inc. · NCT07503873A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of a New Subcuta
Phase 1 · 12 location(s) · Hoffmann-La Roche · NCT07667322The Effect of a Muscle-mimicking, Fabric-type Shoulder Orthosis on Functional Movements of the Upper Limb in Patients Wi
NA · 1 location(s) · Seoul National University Hospital · NCT06363357A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
Phase 1 · 14 location(s) · CRISPR Therapeutics · NCT06925542Clinical Study to Evaluate the Efficacy and Safety of FB1006 in the Treatment of ALS Patients
Phase 4 · 1 location(s) · Peking University Third Hospital · NCT05923905Escalation vs. Induction Therapy Strategy in Patients With Early-Onset MS After Age 50
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT07313462Axatilimab for Sclerotic Chronic Graft-versus-Host Disease
Phase 2 · 3 location(s) · Fred Hutchinson Cancer Center · NCT07011810Home Based Infusions for Ocrelizumab
Phase 4 · 1 location(s) · University of Colorado, Denver · NCT04650321Exploring the Gut-Brain Axis in Ageing and Neurodegeneration
Phase N/A · 3 location(s) · IRCCS San Camillo, Venezia, Italy · NCT05934188Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis
Phase 4 · 1 location(s) · Northwestern University · NCT07225361A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-
Phase N/A · 1 location(s) · Biogen · NCT07259980Clinical Outcome Assessment for AT & BCI
NA · 1 location(s) · Shirley Ryan AbilityLab · NCT07407725Biomarkers in Different Types of Amyotrophic Lateral Sclerosis (ALS) Patients Being Treated With Edaravone
Phase N/A · 1 location(s) · Loma Linda University · NCT04097158Fall Prevention Among People With Spinal Cord Injury and Multiple Sclerosis Who Use Wheelchairs and Scooters
NA · 1 location(s) · University of Illinois at Urbana-Champaign · NCT07167680China National Registry of Neuro-Inflammatory Diseases
Phase N/A · 1 location(s) · Beijing Tiantan Hospital · NCT05154370MS-NEUROPLAST: Neuroplasticity of Cortical Areas Induced by Cognitive Training in Patients with Multiple Sclerosis
NA · 1 location(s) · Aristotle University Of Thessaloniki · NCT04806568A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases
Phase 1 · 2 location(s) · Beijing GoBroad Hospital · NCT06980597Study of COYA 302 for the Treatment of ALS
Phase 2 · 25 location(s) · Coya Therapeutics · NCT07161999
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.